awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38722972-10EA1135-89EA-4946-894F-724AE56F6A40
Q38722972-10EA1135-89EA-4946-894F-724AE56F6A40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38722972-10EA1135-89EA-4946-894F-724AE56F6A40
Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States.
P2860
Q38722972-10EA1135-89EA-4946-894F-724AE56F6A40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38722972-10EA1135-89EA-4946-894F-724AE56F6A40
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7c02f37ee95be0437e1dc74d9772a0160d627b8a
P2860
Costs of first-line doublet chemotherapy and lifetime medical care in advanced non-small-cell lung cancer in the United States.